Does Medicare cover PCSK9 inhibitors like Repatha and Praluent?
Answered by 12 licensed agents
đź’ˇ Coverage and Formularies
• High Adoption: Around 83% to 95% of Medicare Part D and Advantage plans cover Repatha, while Praluent is also widely included depending on the specific insurer's formulary.
• Tier Placement: Usually placed on Specialty Tiers (Tier 5), meaning cost-sharing is a percentage of the drug's cost rather than a flat copay.
• Out-of-Pocket Cap: Total yearly out-of-pocket spending for Part D drugs is capped at $2,100, which limits maximum yearly costs if you hit the threshold.
⚠️ Approval Requirements
• Prior Authorization: Nearly all covering plans require your doctor to submit proof of medical necessity before approval.
• Step Therapy: Insurers typically require documentation that you tried and failed or could not tolerate maximally dosed statins alongside other adjuncts like ezetimibe first.
Answered by Mark Boone on October 5, 2026
Agent Licensed in MN, FL, MI & NC, OH, SC & VA
Because Repatha and Praluent are medications you typically inject yourself, they are generally covered through Medicare Part D, rather than Part B. Medicare Part B mainly covers a limited group of medications that are given in a doctor's office or other outpatient medical setting.
The important part is that every Part D plan has its own formulary, or list of covered drugs. One plan may cover Repatha, another may prefer Praluent, and some plans may place additional requirements on coverage.
These medications may require prior authorization, step therapy, or documentation from your doctor showing why the medication is medically necessary. Medicare drug plans are allowed to use these coverage rules.
If your doctor prescribes Repatha or Praluent, check your exact Part D or Medicare Advantage drug formulary before assuming it is covered. If the prescribed medication is not covered, ask whether the plan prefers another PCSK9 inhibitor or whether your doctor can request a formulary exception.
So the short answer is yes, Medicare drug coverage may cover Repatha or Praluent, but you need to check the exact plan because coverage and approval requirements can vary.
Answered by Jeremy Harkins on September 25, 2026
Broker Licensed in TN, AR, CA & 5 other states
These medications are usually covered under Part D, and the insurance company may require prior authorization or other criteria before approving them. Coverage and out-of-pocket costs can vary considerably from one plan to another.
If you’re already taking Repatha or Praluent, or your doctor is considering prescribing one, I would recommend checking your specific plan’s formulary and coverage requirements before assuming it’s covered.
This is also why it’s so important to include all of your medications when comparing Medicare plans each year. The plan with the lowest monthly premium isn’t necessarily the plan that will cost you the least overall.
Answered by Cody Biggs on August 20, 2026
Broker Licensed in LA, AL, AZ & 24 other states
Approximately 90% to 95% of Medicare prescription plans include at least one PCSK9 inhibitor on their formulary, but getting approval and managing the costs requires navigating a few specific rules.
Answered by Christopher Horan on October 5, 2026
Agent Licensed in PA, DE, FL & NJ, NY, TX & VA
medicare.gov
Plans may require prior authorization or step therapy—for example, documentation of your diagnosis and that other cholesterol medicines were tried or weren’t suitable. Your cost depends on your plan’s formulary tier and pharmacy.
medicare.gov
To check, look up the exact medicine—Repatha (evolocumab) or Praluent (alirocumab)—in your plan’s formulary, or use Medicare’s Plan Finder. In 2026, your out-of-pocket spending on covered Part D drugs is capped at $2,100 for the year; that doesn’t guarantee coverage for a drug your plan excludes.
medicare.gov
If your plan denies coverage, you or your prescriber can request a coverage determination or an exception.
medicare.gov
Answered by John Hose on November 9, 2026
Broker Licensed in MD, FL, NC & 7 other states
Answered by Corey Bennett on August 26, 2026
Broker Licensed in IN
Answered by Mark Bilgere on August 26, 2026
Broker Licensed in TX, AR, IN & LA, MN, NE & OK
Answered by Kenneth Parsons on August 20, 2026
Agent Licensed in NM, AZ & TX
Answered by Cynthia (Cindy) Dixon on October 26, 2026
Broker Licensed in AR, MO, MS, OK, TN & TX
Answered by Michelle Hylton on August 21, 2026
Broker Licensed in AL, CA, FL & 5 other states
Answered by Marcia West on August 18, 2026
Agent Licensed in WA, FL, GA, MI, TX & VA
Answered by Michael Ferraro on October 5, 2026
Agent Licensed in NY
Tags: Coverage Medicare Part D Prescription Drug
Agents: Share Your Expertise
Have insights or experiences related to this topic? Help others by sharing your knowledge and answering this question.
Seniors: Ask a Question of Your Own
Questions are generally answered within 1 to 3 business days. Receive valuable perspectives from multiple licensed agents and brokers.
Ask a Question










